Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial

BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) who were naive to anticholinergics before the TIOtropium Safety and Performance In Respimat (TIOSPIR) trial may reflect patients seen in practice, in particular in primary care. In addition, investigating safety in these patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wise, Robert, Calverley, Peter MA, Dahl, Ronald, Dusser, Daniel, Metzdorf, Norbert, Müller, Achim, Fowler, Andy, Anzueto, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634206/
https://www.ncbi.nlm.nih.gov/pubmed/26540491
http://dx.doi.org/10.1038/npjpcrm.2015.67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634206/
https://www.ncbi.nlm.nih.gov/pubmed/26540491
http://dx.doi.org/10.1038/npjpcrm.2015.67

Ejemplares similares